Sopharma AD-Sofia (FRA:3JR) Change In Payables And Accrued Expense : €0.0 Mil (TTM As of Dec. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Sopharma AD-Sofia Change In Payables And Accrued Expense?

Sopharma AD-Sofia's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was €0.0 Mil. It means Sopharma AD-Sofia's Accounts Payable & Accrued Expense stayed the same from Sep. 2023 to Dec. 2023 .

Sopharma AD-Sofia's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was €0.0 Mil. It means Sopharma AD-Sofia's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

Sopharma AD-Sofia Change In Payables And Accrued Expense Historical Data

The historical data trend for Sopharma AD-Sofia's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sopharma AD-Sofia Change In Payables And Accrued Expense Chart

Sopharma AD-Sofia Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

Sopharma AD-Sofia Quarterly Data
	Dec18	Mar19	Jun19	Sep19	Dec19	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-	-	-	-	-

Sopharma AD-Sofia Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.0 Mil.

Sopharma AD-Sofia Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Sopharma AD-Sofia's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Sopharma AD-Sofia (FRA:3JR) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Sopharma AD-Sofia (FRA:3JR) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

SPH:Poland SFA:Bulgaria

Address

5 Lachezar Stanchev Street, Sopharma Business Towers, Building A, Floor 11, Sofia, BGR, 1756

Website

https://www.sopharmagroup.com

Sopharma AD-Sofia is a company engaged in the production of pharmaceutical products. Its principal activities include the production and trade of medicinal substances and finished drug forms; and research and development as well as engineering and implementation activities in the field of medicinal products. It is also focused on the distribution of pharmaceuticals like medical supplies, sanitary materials, vitamins, food supplements, and cosmetics. The company's segments are organized based on the production of finished products which include Tablet dosage forms, Ampoule dosage forms, Medical products, Other forms, and Other revenue. Geographically company operates in Bulgaria and internationally.

Sopharma AD-Sofia (FRA:3JR) Headlines

No Headlines